ABCL

Q: What is the price of AbCellera Biologics (ABCL) today?

The price of AbCellera Biologics (ABCL) today is US$ 5,86, with a variation of 104.18% compared to the last year. The price of AbCellera Biologics (ABCL) started the year trading around US$ 2,93 and today it is at US$ 5,86. Follow the real-time price chart, the historical price of AbCellera Biologics (ABCL), and stock data from Ibovespa and international markets.

Q: When does AbCellera Biologics (ABCL) pay dividends?

AbCellera Biologics (ABCL) não distribuiu dividendos no último ano.

Q: AbCellera Biologics (ABCL) is it worth it?

Currently, AbCellera Biologics (ABCL) is priced at US$ 5,86, with a P/E of -10,09%, representing a deviation of 3,53% from its historical average P/E. In the last year, the stock showed a variation of 104.18% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 104,18%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of AbCellera Biologics (ABCL)?

Investing in stocks of AbCellera Biologics (ABCL) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of AbCellera Biologics (ABCL) yield today?

The yield of AbCellera Biologics (ABCL) was 29,93% in the last month, 104,18% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of AbCellera Biologics (ABCL) today, the total investment would be US$ 586,00, based on the current price of US$ 5,86.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 1.196,49In 5 years: US$ 586,00In 10 years: 586,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AbCellera Biologics Inc.

Price

US$ 5,86

variation (12m)

104,18%

p/l

-10,09

p/vp

1,66

DIVIDEND YIELD

0,00%

price ABCL

BVMF

ABCL

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of ABCL

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

29,93%

3 months

19,11%

1 year

104,18%

2 years

35,65%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

29,93%

3 months

18,67%

1 year

95,23%

2 years

23,81%

5 years

0,00%

10 years

0,00%

Indicators ABCL

check out the fundamentals of AbCellera Biologics shares

P/E

-10,09

Sector: -2,32 Industry: 0,11

P/SALES RATIO (PSR)

50,83

Sector: 2,02 Industry: 0,83

P/BV

1,66

Sector: 2,20 Industry: 2,21

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-11,82%

Sector: -27,89% Industry: -12,08%

ROE

-16,45%

Sector: -32,67% Industry: -42,22%

ROIC

-23,29%

Sector: -403,82% Industry: -113,08%

NET MARGIN

-100,00%

Sector: -27,27% Industry: -11,46%

GROSS MARGIN

100,00%

Sector: 44,14% Industry: 31,46%

OPERATING MARGIN

-100,00%

Sector: -23,95% Industry: -8,82%

P/EBITDA

-8,44

Sector: -0,69 Industry: 1,68

P/EBIT

-6,34

Sector: -2,33 Industry: -0,47

P/ASSET

1,19

Sector: 1,26 Industry: 0,93

BVPS

3,37

Sector: 3,60 Industry: 5,78

EPS

-0,55

Sector: -0,82 Industry: -0,12

EQUITY / ASSETS

0,72

Sector: 0,45 Industry: 0,28

CAGR REVENUES 5 YEARS

-32,41%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

ABCL indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	52,24	39,29	75,21%	0,72%	US$ 720,94 B	25,91%
ISRG	61,42	8,92	14,52%	0,00%	US$ 160,16 B	28,51%
TMO	30,94	4,03	13,01%	0,31%	US$ 203,71 B	15,24%
SNY	11,01	1,53	13,90%	4,37%	US$ 124,07 B	14,83%
MDT	26,35	2,55	9,68%	2,94%	US$ 122,79 B	13,63%
CVS	22,86	1,34	5,84%	3,25%	US$ 103,58 B	1,17%
ABT	15,96	4,39	27,50%	1,81%	US$ 223,05 B	32,43%
GSK	19,82	4,58	23,12%	3,75%	US$ 89,23 B	10,87%
NVS	18,75	6,09	32,47%	2,94%	US$ 256,03 B	24,74%
BSX	58,63	6,48	11,06%	0,00%	US$ 146,88 B	13,54%
TMDX	55,80	12,57	22,53%	0,00%	US$ 4,00 B	13,49%
HCA	17,20	-82,96	-482,31%	0,66%	US$ 102,70 B	8,21%
DHR	43,84	2,86	6,52%	0,57%	US$ 149,63 B	14,21%
INMD	5,40	1,53	28,44%	0,00%	US$ 964,53 M	44,50%
IDXX	51,57	34,84	67,57%	0,00%	US$ 50,83 B	24,41%
FMS	21,85	0,96	4,42%	2,90%	US$ 15,94 B	3,41%
PHG	128,40	2,25	1,75%	3,11%	US$ 26,98 B	1,07%
HUM	21,04	1,81	8,61%	1,29%	US$ 33,16 B	1,28%
RMD	27,94	6,56	23,47%	0,82%	US$ 39,14 B	27,22%

comparison of ABCL with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History ABCL

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY AbCellera Biologics

AbCellera Biologics Inc.

Average user rating I10

4.0 (3 people)

Estados Unidos

13 years

Foundation: 2012

2020

Year of debut on the stock exchange - 5 years

206

Employees

The Company AbCellera Biologics Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1,67 Billion, having a net worth of $ 1,01 Billion.

With a total of 206 employees, the company is listed in the sector of Health and categorized in industry of Life Science Tools and Services.

In the last 12 months the Company had a revenue of $ 32,88 Milhões, which generated a loss in the amount of $ -165,67 Milhões.

As for its main indicators, the Company has a P/E ratio of -10,09, a P/BV ratio of 1,66 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ABCL.

Market value

US$ 1,67 Billion

Net worth

US$ 1,01 Billion

US$ 1.007.080.000,00

Assets

US$ 1,40 Billion

US$ 1.402.060.000,00

Total Number of Shares

299,00 Milhões

299.000.000

Average Daily Trading Volume

US$ 5,42 Milhões

US$ 5.419.092,58

Sector

Health

Industry

Life Science Tools and Services

ABCL

ABCL revenue and profits

ABCL results

DRAG THE FRAME TO SEE MORE DATA

ABCL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

ABCL

AbCellera Biologics Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of ABCL

check out the fundamentals of AbCellera Biologics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY AbCellera Biologics

AbCellera Biologics Inc.

Estados Unidos

13 years

2020

206

PROFIT X PRICE ABCL

ABCL results

ABCL cash flow

evolution of assets - ABCL

ABCL balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions